What we do

Turicum Investment Management AG (TIM) is an independent advisory firm founded in 1999. The company is licensed as an investment manager and supervised by the Swiss Financial Market Supervisory Authority (FINMA).

By fostering a culture of discipline, openness, and transparency, we have become a trusted partner for investors. We provide a variety of solutions to capture emerging trends and early recognition investment opportunities.

Along with our diverse range of investments, one of our primary areas of focus is Vietnam, the rising tiger of Asia.
OUR TEAM
HAS AN EXTENSIVE
TRACK RECORD
TIM is dedicated to providing expertise while adhering to the highest ethical standards. By coupling fundamental analysis with in-depth country and industry knowledge, we specifically tailor investment solutions to the precise needs of investors.
Find out more navigation_button
+
Years in business
+
NUMBER OF COMPANIES
COVERAGE
+
YEARS OF COMBINED
EXPERIENCE
+
TEAM MEMBERS
Find out more navigation_button
Vietnam July 2025 Economic Outlook & Stock Market: Trade, Tourism, and Stocks Outperform

We would like to present you our monthly Macroeconomic & Stock Market Highlights for Vietnam alongside with the monthly performance update of the TIM Vietnam Actively Managed Certificate for July 2025. Watch our video recap of key takeaways of the Vietnam Marcroeconomic and Stock market in July 2025 Vietnam’s Update – Economy Vietnam has confirmed its trade […]

Find out more navigation_button
monthly-hightlight-image
News & Insights
Find out more navigation_button
news

According to Ministry of Finance, Vietnam’s public debt-to-GDP ratio has fallen sharply from nearly 56% in 2020 to just 34% in 2024, well below the statutory ceiling of 60%. This is not only a remarkable fiscal consolidation within just a few years but also places Vietnam at a much lower level than many regional peers. […]

Read Newsarrow
news

Summary of Q2 2025 results and outlook of Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD VN) Net revenue rose 12.1% y/y to VND916 billion. By product category, the three strategic segments—Antibiotics (+14.8% y/y), Oncology (+13.8% y/y), and Dialysis solutions (+30.9% y/y)—together accounted for 63.5% of total sales. By distribution channel, the hospital segment, which […]

Read Newsarrow
news

Summary of Q2 2025 results and outlook of Binh Minh Plastics JSC (BMP VN) Net revenue reached VND2,691bn (+24.8% y/y), driven by a 25.5% y/y increase in sales volume. Growth was supported by an early recovery in real estate construction and the front-loaded timing of promotional campaigns (held in Q1 and end-Q2 vs. Q3 in […]

Read Newsarrow
Find out more navigation_button